Brugts J J, Manintveld O C, van Mieghem N
Erasmus MC Thorax Center, Rotterdam, The Netherlands.
Neth Heart J. 2018 Feb;26(2):55-57. doi: 10.1007/s12471-017-1054-4.
We report the first patient experiences with the CardioMEMS device in the Erasmus MC Thorax Center in the Netherlands. In line with clinical trial evidence, the device is applicable in patients with chronic heart failure in functional New York Heart Association class III with at least 1 admission for heart failure in the past 12 months. CardioMEMS has been shown to be safe and reliable, and effective in reducing the number of hospitalisations for heart failure by guided therapy based on pulmonary artery pressures.
我们报告了荷兰伊拉斯姆斯医学中心胸科中心首例使用CardioMEMS设备的患者体验。与临床试验证据一致，该设备适用于纽约心脏协会功能分级为III级的慢性心力衰竭患者，且在过去12个月内至少因心力衰竭住院1次。CardioMEMS已被证明是安全可靠的，并且通过基于肺动脉压力的指导治疗，在减少心力衰竭住院次数方面是有效的。
